Valens Molecules Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 10.88 Cr
as on 24-10-2024
- Company Age 30 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 73.26 Cr
as on 24-10-2024
- Satisfied Charges ₹ 66.47 Cr
as on 24-10-2024
- Revenue 10.45%
(FY 2023)
- Profit 56.21%
(FY 2023)
- Ebitda 49.25%
(FY 2023)
- Net Worth 20.00%
(FY 2023)
- Total Assets -9.59%
(FY 2023)
About Valens Molecules
The Corporate was formerly known as Posh Chemicals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 10.88 Cr.
The company currently has active open charges totaling ₹73.26 Cr. The company has closed loans amounting to ₹66.47 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Valens Molecules Private Limited India is Baga Mettu as COMPANY SECRETARY. Cherukuri Prasad, Mulukutla Sastry, Cherukuri Poshya, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24100TG1994PTC018680
- Company No.
018680
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Nov 1994
- Date of AGM
12 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Valens Molecules?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Cherukuri Prasad  | Managing Director | 02-May-1995 | Current |
| Baga Mettu | Company Secretary | 01-Apr-2017 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mulukutla Sastry | Director | 28-Aug-2001 | Current |
| Cherukuri Poshya | Whole-Time Director | 26-Aug-2006 | Current |
| Padmasree Cherukuri | Whole-Time Director | 02-Nov-1994 | Current |
| Cherukuri Prakash | Whole-Time Director | 27-Sep-2010 | Current |
| Rahul Yalamanchili | Whole-Time Director | 07-Jan-2013 | Current |
Financial Performance and Corporate Structure Insights of Valens Molecules.
Valens Molecules Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.45% increase. The company also saw a substantial improvement in profitability, with a 56.21% increase in profit. The company's net worth Soared by an impressive increase of 20%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Valens Molecules?
In 2023, Valens Molecules had a promoter holding of 94.96% and a public holding of 5.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jeedimetla Effluent Treatment Limited.Active 37 years 10 monthsCherukuri Prakash is a mutual person
- Enpharm Private LimitedActive 12 years 9 months
Cherukuri Poshya and Rahul Yalamanchili are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 May 2024 | ₹9.70 M | Open |
Others Creation Date: 21 Dec 2023 | ₹1.06 Cr | Open |
Others Creation Date: 03 Nov 2023 | ₹3.00 M | Open |
How Many Employees Work at Valens Molecules?
Valens Molecules has a workforce of 178 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Valens Molecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valens Molecules's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
